These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 9870252)

  • 1. Role of donor versus recipient type Epstein-Barr virus in post-transplant lymphoproliferative disorders.
    Haque T; Crawford DH
    Springer Semin Immunopathol; 1998; 20(3-4):375-87. PubMed ID: 9870252
    [No Abstract]   [Full Text] [Related]  

  • 2. The antiviral prophylaxis of post-transplant lymphoproliferative disorder.
    Davis CL
    Springer Semin Immunopathol; 1998; 20(3-4):437-53. PubMed ID: 9870256
    [No Abstract]   [Full Text] [Related]  

  • 3. Adoptive immunotherapy for Epstein-Barr virus-associated lymphoproliferative disorders complicating marrow allografts.
    O'Reilly RJ; Small TN; Papadopoulos E; Lucas K; Lacerda J; Koulova L
    Springer Semin Immunopathol; 1998; 20(3-4):455-91. PubMed ID: 9870257
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunotherapy for Epstein-Barr virus-associated malignancies.
    Long HM; Parsonage G; Fox CP; Lee SP
    Drug News Perspect; 2010 May; 23(4):221-8. PubMed ID: 20520851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus gene expression in post-transplant lymphoproliferative disorders.
    Rowe M; Niedobitek G; Young LS
    Springer Semin Immunopathol; 1998; 20(3-4):389-403. PubMed ID: 9870253
    [No Abstract]   [Full Text] [Related]  

  • 6. Preventing Epstein-Barr virus lymphoproliferative disease after bone marrow transplantation.
    Heslop HE
    J Immunother; 2001; 24(4):283-4. PubMed ID: 11565828
    [No Abstract]   [Full Text] [Related]  

  • 7. Epstein-Barr virus and posttransplant lymphoproliferative disease.
    Holmes R
    J Pediatr Gastroenterol Nutr; 2001 Oct; 33(4):442-4. PubMed ID: 11698760
    [No Abstract]   [Full Text] [Related]  

  • 8. B lymphocytes and Epstein-Barr virus: the lesson of post-transplant lymphoproliferative disorders.
    Dolcetti R
    Autoimmun Rev; 2007 Dec; 7(2):96-101. PubMed ID: 18035317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune-cell treatment of Epstein--Barr-virus-associated lymphoproliferative disorders.
    Swinnen LJ
    Best Pract Res Clin Haematol; 2006; 19(4):839-47. PubMed ID: 16997187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of semiquantitative polymerase chain reaction for Epstein-Barr virus to measure virus load in pediatric organ transplant recipients with and without posttransplant lymphoproliferative disease.
    Allen U; Hebert D; Petric M; Tellier R; Tran D; Superina R; Stephens D; West L; Wasfy S; Nelson S
    Clin Infect Dis; 2001 Jul; 33(2):145-50. PubMed ID: 11418872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention and treatment of Epstein-Barr virus-associated lymphoproliferative disorders in recipients of bone marrow and solid organ transplants.
    Meijer E; Dekker AW; Weersink AJ; Rozenberg-Arska M; Verdonck LF
    Br J Haematol; 2002 Dec; 119(3):596-607. PubMed ID: 12437632
    [No Abstract]   [Full Text] [Related]  

  • 12. Review of Epstein-Barr virus and post-transplant lymphoproliferative disorder post-solid organ transplantation.
    Lim WH; Russ GR; Coates PT
    Nephrology (Carlton); 2006 Aug; 11(4):355-66. PubMed ID: 16889577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lymphoproliferative syndromes associated to the Epstein Barr virus in organ transplants].
    Hidalgo M; Lumbreras C; Aguado JM
    Med Clin (Barc); 1996 Sep; 107(8):310-6. PubMed ID: 8965496
    [No Abstract]   [Full Text] [Related]  

  • 14. Early intervention in post-transplant lymphoproliferative disorders based on Epstein-Barr viral load.
    Hoshino Y; Kimura H; Kuzushima K; Tsurumi T; Nemoto K; Kikuta A; Nishiyama Y; Kojima S; Matsuyama T; Morishima T
    Bone Marrow Transplant; 2000 Jul; 26(2):199-201. PubMed ID: 10918431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Quantitative analysis of Epstein-Barr virus (EBV)-specific CD8+ T lymphocytes in EBV-related diseases].
    Kuzushima K
    Rinsho Ketsueki; 2000 Jun; 41(6):487-90. PubMed ID: 10921347
    [No Abstract]   [Full Text] [Related]  

  • 16. Complete regression of posttransplant lymphoproliferative disease using partially HLA-matched Epstein Barr virus-specific cytotoxic T cells. Transplantation 2001; 72: 1399.
    Khanna A
    Transplantation; 2001 Oct; 72(8):1352-3. PubMed ID: 11685102
    [No Abstract]   [Full Text] [Related]  

  • 17. Successful treatment of a classic Hodgkin lymphoma-type post-transplant lymphoproliferative disorder with tailored chemotherapy and Epstein-Barr virus-specific cytotoxic T lymphocytes in a pediatric heart transplant recipient.
    Basso S; Zecca M; Calafiore L; Rubert L; Fiocchi R; Paulli M; Quartuccio G; Guido I; Sebastiani R; Croci GA; Beschi C; Nardiello I; Ginevri F; Cugno C; Comoli P
    Pediatr Transplant; 2013 Nov; 17(7):E168-73. PubMed ID: 23992468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EBV specific CTL: a model for immune therapy.
    Rooney CM; Heslop HE; Brenner MK
    Vox Sang; 1998; 74 Suppl 2():497-8. PubMed ID: 9704488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Posttransplant lymphoproliferative disease, monoclonal, Epstein-Barr virus related.
    Petrovic LM
    Liver Transpl; 2001 May; 7(5):451-2. PubMed ID: 11349267
    [No Abstract]   [Full Text] [Related]  

  • 20. Simian virus 40 in posttransplant lymphoproliferative disorders.
    Vilchez RA; Jauregui MP; Hsi ED; Novoa-Takara L; Chang CC
    Hum Pathol; 2006 Sep; 37(9):1130-6. PubMed ID: 16938517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.